Last updated: 2026-10-13 23:14:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Edwards Lifesciences Corp. (EW) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $85.27, with a market capitalization of $49.12B and a P/E ratio of 49.55. Over the past 52 weeks, its price has ranged from $72.30 to $96.29. This page covers its latest market performance, valuation, price trends and company information.
$49.12B | |
$86.55 | |
$131.73 | |
$2.23 | |
$86.39 | |
2.20M | |
3.82M | |
49.55 | |
$96.29 | |
$72.30 | |
-- | |
-- |
Edwards Lifesciences Corp. (EW) is trading at $85.75 in after-hours trading as of 2026-10-13 22:30:00, down 0.74% ($0.64) from the regular-session close of $86.39.
After-hours trading shows how investors are pricing EW after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Edwards Lifesciences Corp. (EW) moved from $85.15 to $85.27, representing a gain of 0.14% ($0.12).
The stock traded between $82.43 and $87.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 3.76 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 54.1%
EW is currently trading at $85.27, placing it 54.1% of the way from its 52-week low of $72.30 to its 52-week high of $96.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 16000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Edwards Lifesciences Corp. (EW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.